News & Articles
Selected Filters:
World-class speaker lineup announced for Virtual Neuroscience Summit 2020
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Study shows early treatment for leg ulcers leads to better outcomes for patients
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
Abbott receives CE mark for MitraClip heart valve repair device to treat mitral regurgitation
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
DiaSorin's Simplexa COVID-19 direct molecular test CE marked for saliva specimens
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
Roche granted FDA clearance for BK virus test to support better care for transplant patients
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
DiaSorin partners with MeMed to develop and commercialize diagnostics solution
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
Sherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Teknova scales up production of viral transport media to support global response to COVID-19
Rapid increase in production of VTM and saline will help boost virus testing
Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to support COVID-19 diagnosis
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions
Abbott's 15-minute, $5 COVID-19 antigen test receives FDA emergency use authorization
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
Luminex files for emergency use of expanded NxTAG Respiratory Panel test
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
FDA clears AI-based MRI interpretation assistants from Siemens Healthineers
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
FDA clears Siemens Healthineers' bedside computed tomography scanner
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
QIAGEN to launch easy-to-use test in the U.S. for rapid detection of SARS-CoV-2 antibodies
Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies
The mysteries of intensive care medicine unraveled
Join us on Tuesday, September 1, to learn about why patients are admitted to an intensive care unit and what is available in terms of physiological support, monitoring, and treatments
COVID-19 testing using lateral flow assays: sensitive, rapid, easy to use and point-of-care
Learn about the potential of lateral flow assays in detecting symptomatic and asymptomatic COVID-19 infections
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
Abbott announces start of study to evaluate new device to treat recurrent atrial fibrillation
Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation
9 top resources for your COVID-19 & infectious disease research
Exclusive interviews, new methods, free downloads, and much more to help you advance your work























